Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2

Status

Active not recruiting 3Withdrawn 2Recruiting 1Completed 1

Sponsor Class

OTHER 154INDUSTRY 92NIH 9NETWORK 7OTHER_GOV 2

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 8Thoracic 7Head & Neck 3Genitourinary 3Breast 3Tumor-Agnostic 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Squamous Non-small Cell Lung Cancer 1Small Cell Lung Carcinoma 1Lung Cancer Metastatic 1

Interventions

Carboplatin 41Cisplatin 40Paclitaxel 35Radiotherapy 32Docetaxel 19Pemetrexed 18Gemcitabine 17Etoposide 17Bevacizumab 11Radiosurgery 10Magnetic Resonance Spectroscopy 9Ramucirumab 8durvalumab 7Taxes 7Cetuximab 7pembrolizumab 6Specimen Handling 6Erlotinib Hydrochloride 6Irinotecan 5Gene Expression Profiling 5Filgrastim 5cediranib 4Vinorelbine 4Polymerase Chain Reaction 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Chemotherapy, Adjuvant 4Amplified Fragment Length Polymorphism Analysis 4tremelimumab 3osimertinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
NETWORK × durvalumab × Thoracic × Clear all
NCT01993810 2026-05-27

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
330 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06769126 2026-03-30

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

SWOG Cancer Research Network

Phase 2 Recruiting
900 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03057106 2026-03-03

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Canadian Cancer Trials Group

Phase 2 Active not recruiting
301 enrolled 15 charts
Thoracic

Lung Cancer Metastatic

NCT03965468 2026-02-09

CHESS

ETOP IBCSG Partners Foundation

Phase 2 Active not recruiting
96 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02273375 2025-08-12

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

Canadian Cancer Trials Group

Phase 3 Active not recruiting
1,415 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05718297 2024-10-08

BOUNCE

ETOP IBCSG Partners Foundation

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03319316 2022-01-10

SOLUTION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn
Thoracic

Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡